According to data from the literature resveratrol and others sirtuin 1 activators have demonstrated promising outcomes in a wide range of age-related diseases including obesity, diabetes, inflammation, cardiovascular disease, among others (60–64). Here, SIRT1 is linked to cardiovascular disorder.